TB-500 is a synthetic peptide derived from the active region of thymosin β4, known for its remarkable biological activities. This pharmaceutical grade raw powder demonstrates exceptional purity levels exceeding 99%, making it suitable for advanced research applications.
The TB-500 fragment exhibits significant potential in promoting angiogenesis and supporting tissue repair mechanisms. Research indicates its effectiveness in enhancing endothelial cell differentiation and facilitating keratinocyte migration. The compound's anti-inflammatory properties contribute to reduced swelling and pain responses in experimental models.
TB-500 demonstrates particular relevance in studies involving chronic inflammation conditions and cardiovascular research. Its ability to stimulate stem cell production positions TB-500 as a valuable compound for tissue regeneration studies. The molecular structure of TB-500 ensures stable biological activity while maintaining consistent performance characteristics.
This TB-500 raw material undergoes rigorous quality control procedures to guarantee batch-to-batch consistency. Analytical testing includes HPLC purity verification and comprehensive spectral analysis. The product's physical properties, including solubility and stability parameters, are thoroughly documented to support research reproducibility.
As a specialized peptide intermediate, TB-500 requires proper handling and storage conditions to maintain integrity. Researchers should follow established protocols for reconstitution and application. The material is provided with detailed analytical documentation supporting its pharmaceutical grade classification.
This product is supplied exclusively for research applications and laboratory use. Proper safety protocols must be observed during handling and experimentation. Researchers are responsible for ensuring compliance with applicable regulations governing peptide research in their jurisdiction.